Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 567 is part of the zinc finger protein (ZNF) superfamily, the largest group of transcription factors in the human genome. Members of this family typically contain one or more zinc finger motifs—short structural domains stabilized by zinc ions that facilitate binding to DNA, RNA, or proteins and mediate transcriptional regulation[1][2][5]. ZNF567 is annotated as a protein-coding gene in major databases, with predicted localization in the nucleus, and is assumed to function as a DNA-binding transcription factor of the C2H2-type, the most prevalent zinc finger motif in human proteins[5]. There are no published reports describing ZNF567 as a validated therapeutic target, and no literature links this gene or protein specifically to drug interactions, disease mechanisms, or biomarker use. Most references to ZNF567 are in the context of genomic cataloguing or predicted protein-coding gene sets, not functional or mechanistic investigation. Zinc finger proteins as a group play fundamental roles in transcription regulation, chromatin remodeling, and a wide range of gene regulatory processes, with established importance in development and disease for some specific family members[1][2][5]. The specific biological function, disease relevance, and interactome of ZNF567 remain uncharacterized; this is typical for many “orphan” zinc finger genes. There is no evidence of ZNF567 being a validated or even hypothesized drug target. No interacting drugs, mechanisms of action, or safety/biomarker information is available. ZNF567-DT is a divergent transcript of ZNF567, described as a non-coding RNA gene associated with osteoarthritis in lncRNA studies, but that is a distinct gene transcriptional product[4]. In summary, Zinc finger protein 567 (ZNF567) is a putative human transcription factor of the C2H2 zinc finger protein family, annotated based on sequence homology but lacking detailed biological or therapeutic data. No drugs or clinical roles are currently described for this protein, and it is not considered a therapeutic target based on available evidence[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 567 (ZNF567).